The Clinical Significance of Monitoring Expression Level of Sil-Tal1 Fusion Gene after Allogeneic Hematopoietic Stem Cell Transplantation
Xiaosu Zhao,Yan Hong,Yazhen Qin,Yingjun Chang,Xiaohui Zhang,Lanping Xu,Xiao Jun Huang
DOI: https://doi.org/10.1182/blood.v128.22.5800.5800
IF: 20.3
2016-01-01
Blood
Abstract:Objective SIL-TAL1 rearrangement is common in T-cell acute lymphoblastic leukemia (T-ALL). However, whether this fusion gene could be used as a reliable marker of minimal residual disease (MRD) after allogeneic stem cell transplantation (allo-HSCT) remains unknown. This study purposed to investigate the clinical significance of monitoring level of SIL-TAL1 fusion gene in patients with T-ALL after allo-HSCT.
What problem does this paper attempt to address?